. Having said that, toxicity of those hugely successful PKC agonists is an ongoing concern, and necessity to deliver the medicine via injection. Now, artificial analogs of bryostatin58,59 and prostratin60 are now being explored, with diminished toxicity and price of synthesis in contrast with their purely natural resource counterparts. Released https://davys875nqp5.blogofchange.com/profile